Target intelligence / Profile preview

Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature)

Target
None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature
Molecular classification
Other (structure; not a receptor, enzyme, ion channel, or transporter), Cellular membrane, Composite of integral and peripheral membrane proteins, and lipids
01

Overview

The **erythrocyte cell membrane** is the specialized plasma membrane of red blood cells. It is a composite structure consisting of a lipid bilayer (made of cholesterol and phospholipids) and embedded proteins, providing elastic and mechanical stability, shape, and deformability to the cell. The membrane expresses numerous important blood group antigens (ABO, Rh, Kell, Duffy, etc.), which are crucial for transfusion compatibility. Its interaction with an underlying spectrin-based cytoskeleton confers unique flexibility, allowing erythrocytes to survive the mechanical stress of circulation and pass through narrow capillaries. Specific abnormalities or immune reactions directed against membrane-bound components can result in hemolytic disease or transfusion reactions.

Other names
Red blood cell membraneRBC membraneRBC cell membraneErythrocyte plasma membraneRBCcm
02

Mechanism of action

Not applicable at the structure level. Mechanisms pertain to specific proteins, e.g.:\n- Antibody-mediated destruction of cells presenting specific antigens (RhD, ABO)\n- Inhibition or modulation of ion transporters

03

Biological functions

Gas transport (indirectly, via anchoring hemoglobin and shape maintenance)Maintenance of erythrocyte shape and deformabilityExpression of blood group antigens (ABO, Rh, Kell, Duffy, etc.)Barrier functionCellular adhesionIon transport (via embedded transporters)
04

Disease associations

Hemolytic anemia (due to membrane abnormalities, e.g., hereditary spherocytosis, elliptocytosis)Blood transfusion reactions (via blood group antigens)Parasitic infections (malaria; Plasmodium exploits membrane proteins)Autoimmune hemolysisOther hematological disorders
05

Safety considerations

Hemolytic transfusion reactions if incompatible blood group antigens are presentDamage/mechanical fragility in genetic disorders (hereditary spherocytosis, elliptocytosis)Drug-induced hemolysis or oxidative damage
06

Interacting drugs

None directly target the "erythrocyte cell membrane" as a whole. Drugs and antibodies may interact with specific membrane proteins (e.g., anti-RhD immunoglobulin for Rh incompatibility, malaria-targeting therapies); treatments may affect red cell membrane indirectly (detergents, oxidizing agents in hemolytic anemia). For structured interaction, focus should be on specific antigens or proteins of the membrane.
07

Biomarkers

Blood group antigens (ABO, Rh, Kell, Duffy, etc.) for transfusion compatibility and disease susceptibilityMembrane protein mutations (Band 3, Spectrin, Ankyrin) in inherited anemias

Beyond the preview

Go deeper on Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call